av/eliem-therapeutics--big.svg

NASDAQ:ELYM

Eliem Therapeutics, Inc.

  • Stock

USD

Last Close

8.90

26/07 20:00

Market Cap

478.85M

Beta: -

Volume Today

382.22K

Avg: 17.85K

PE Ratio

−1.98

PFCF: −2.60

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '20
Jun '20
Sep '20
Dec '20
Mar '21
Jun '21
Sep '21
Dec '21
Mar '22
Jun '22
Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Dec '23
Mar '24
net income
-1.92M
-
-1.63M
14.87%
-2.26M
38.44%
-14.86M
558.24%
-18.60M
25.15%
-8.72M
53.13%
-9.62M
10.28%
-10.54M
9.67%
-13.20M
25.22%
-14.60M
10.54%
-9.68M
33.67%
-7.76M
19.83%
-22.29M
187.17%
-5.22M
76.58%
-3.97M
23.98%
-3.64M
8.24%
-1.70M
53.39%
depreciation and amortization
370K
-
193K
47.84%
293K
51.81%
-293K
-
-491K
67.58%
-63K
-
deferred income tax
-1.84M
-
-193K
89.54%
-1.39M
-
stock based compensation
134K
-
51K
61.94%
49K
3.92%
473K
865.31%
297K
37.21%
1.05M
253.54%
1.24M
17.71%
1.15M
6.63%
1.54M
33.54%
1.77M
14.99%
1.78M
0.62%
1.90M
6.28%
10.17M
436.73%
777K
92.36%
656K
15.57%
1.20M
83.23%
465K
61.31%
change in working capital
-460K
-
-2.16M
369.78%
-341K
84.22%
26K
107.62%
-73K
380.77%
-727K
895.89%
-4.59M
531.64%
1.22M
126.57%
406K
66.72%
-2.40M
691.63%
2.69M
211.99%
-484K
117.99%
-2.46M
407.85%
-2.67M
8.71%
7.47M
379.68%
1.42M
80.98%
-640K
145.04%
accounts receivables
inventory
accounts payables
46K
-
-489K
1,163.04%
466K
195.30%
-47K
110.09%
920K
2,057.45%
-129K
114.02%
527K
508.53%
-1.17M
321.63%
-486K
58.39%
146K
130.04%
431K
195.21%
-744K
272.62%
114K
115.32%
14K
87.72%
-142K
1,114.29%
-672K
373.24%
20K
102.98%
other working capital
-506K
-
-1.67M
230.43%
-807K
51.73%
73K
109.05%
-993K
1,460.27%
-598K
39.78%
-5.12M
756.02%
2.39M
146.65%
892K
62.65%
-2.55M
385.65%
2.26M
188.66%
260K
88.49%
-114K
143.85%
-2.69M
2,256.14%
7.62M
383.51%
2.09M
72.51%
-640K
130.58%
other non cash items
-83K
-
-27K
67.47%
169K
725.93%
8.74M
5,071.60%
11.64M
33.15%
-85K
100.73%
4K
104.71%
1.76M
43,950%
478K
72.87%
967K
102.30%
1.03M
6.93%
-415K
140.14%
-109K
73.73%
-850K
679.82%
-671K
21.06%
71K
110.58%
518K
629.58%
net cash provided by operating activities
-2.33M
-
-3.77M
62.06%
-2.38M
36.81%
-5.62M
136.20%
-6.74M
19.84%
-8.48M
25.83%
-12.97M
52.89%
-7.88M
39.20%
-10.78M
36.72%
-13.97M
29.57%
-4.17M
70.11%
-8.45M
102.37%
-15.18M
79.63%
-7.96M
47.52%
3.49M
143.82%
-947K
127.13%
-1.82M
92.08%
investments in property plant and equipment
acquisitions net
purchases of investments
-8.05M
-
-25.58M
217.74%
-8.93M
65.11%
-46.74M
423.66%
-6.71M
85.64%
-17.45M
159.93%
-38.53M
120.79%
-2.46M
93.61%
-1K
99.96%
sales maturities of investments
21.55M
-
24.61M
14.24%
55.25M
124.47%
20.99M
62.01%
23.25M
10.75%
36.93M
58.85%
30.50M
17.42%
36.75M
20.49%
13.75M
62.58%
other investing activites
8.08M
-
net cash used for investing activites
8.08M
-
-106.92M
-
-8.05M
92.47%
-4.04M
49.88%
15.69M
488.80%
8.51M
45.76%
14.28M
67.80%
5.80M
59.40%
-1.60M
127.62%
28.04M
1,851.22%
36.75M
31.07%
13.75M
62.58%
debt repayment
common stock issued
1K
-
24K
2,300%
528K
2,100%
288K
45.45%
15K
94.79%
common stock repurchased
dividends paid
-2.14M
-
-4.55M
-
-2.14M
-
-1.32M
38.25%
other financing activites
4.92M
-
34.08M
592.04%
62.11M
82.23%
83.14M
33.87%
4.59M
94.48%
2.14M
-
1.32M
38.25%
15K
-
net cash used provided by financing activities
4.92M
-
34.08M
592.04%
59.97M
75.94%
83.14M
38.65%
38K
99.95%
-2.14M
-
-1.32M
38.25%
1K
-
24K
2,300%
528K
2,100%
288K
45.45%
15K
94.79%
effect of forex changes on cash
83K
-
27K
67.47%
-169K
725.93%
418K
347.34%
81K
80.62%
85K
4.94%
79K
7.06%
104.54M
132,226.58%
-177K
100.17%
-1.05M
493.79%
-992K
5.61%
1.81M
282.66%
231K
87.25%
399K
72.73%
4K
99.00%
-330K
8,350%
-28K
91.52%
net change in cash
-2.24M
-
-3.74M
66.86%
-2.55M
31.84%
7.80M
405.76%
27.42M
251.73%
51.57M
88.05%
-36.66M
171.09%
-15.90M
56.64%
-14.99M
5.70%
671K
104.48%
3.34M
398.06%
7.64M
128.64%
-9.15M
219.72%
-9.14M
0.05%
32.06M
450.64%
35.76M
11.54%
11.92M
66.67%
cash at beginning of period
21.22M
-
18.98M
10.56%
15.24M
19.71%
12.69M
16.73%
20.49M
61.44%
47.91M
133.86%
99.48M
107.64%
62.82M
36.85%
46.92M
25.31%
31.93M
31.95%
32.60M
2.10%
35.94M
10.25%
43.59M
21.26%
34.44M
20.99%
25.29M
26.55%
57.35M
126.75%
93.11M
62.35%
cash at end of period
18.98M
-
15.24M
19.71%
12.69M
16.73%
20.49M
61.44%
47.91M
133.86%
99.48M
107.64%
62.82M
36.85%
46.92M
25.31%
31.93M
31.95%
32.60M
2.10%
35.94M
10.25%
43.59M
21.26%
34.44M
20.99%
25.29M
26.55%
57.35M
126.75%
93.11M
62.35%
105.03M
12.80%
operating cash flow
-2.33M
-
-3.77M
62.06%
-2.38M
36.81%
-5.62M
136.20%
-6.74M
19.84%
-8.48M
25.83%
-12.97M
52.89%
-7.88M
39.20%
-10.78M
36.72%
-13.97M
29.57%
-4.17M
70.11%
-8.45M
102.37%
-15.18M
79.63%
-7.96M
47.52%
3.49M
143.82%
-947K
127.13%
-1.82M
92.08%
capital expenditure
free cash flow
-2.33M
-
-3.77M
62.06%
-2.38M
36.81%
-5.62M
136.20%
-6.74M
19.84%
-8.48M
25.83%
-12.97M
52.89%
-7.88M
39.20%
-10.78M
36.72%
-13.97M
29.57%
-4.17M
70.11%
-8.45M
102.37%
-15.18M
79.63%
-7.96M
47.52%
3.49M
143.82%
-947K
127.13%
-1.82M
92.08%

All numbers in USD (except ratios and percentages)